The Obesity Drug Loophole. Plus, the Outlook for Homebuilder Stocks.
Barron's Streetwise
Intro
Exploring the recent downturn in US home builder stocks, attributing the decline to an uptick in home inventory rather than high mortgage rates or mixed economic signals, with detailed comparisons to the S&P 500 performance provided.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
